Qualcomm, Honda Lead a Packed Earnings Week
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Wednesday brings a string of S&P 500 results. QUALCOMM posts its Q4 figures after the close today, alongside McDonald's earnings call at 8:30 a.m. eastern. CVS Health also reports this morning. Motorola Solutions, Albemarle, and Corpay are all due after the bell.
Thursday sharpens the auto and tech picture. Honda Motor reports Q2 results, with ORTEX leading-indicator data showing Japanese car registrations running 10% below the same quarter last year through three full months, the strongest available lead on Honda revenue. Polestar Automotive holds its earnings call Thursday morning. Dutch car data, which leads Polestar revenue by 60 days with a strong statistical fit, is running 68% below the year-ago quarter. German car data offers a brighter read: up 32% year-on-year, covering all three months of the quarter. The two signals point in opposite directions. Renault also reports Thursday. Its Austrian car data runs 6% above year-ago levels across all three months, though Dutch data points the other way at minus 21%.
Microchip Technology releases its fiscal Q2 results Thursday after the bell. The chipmaker has flagged weak industrial demand, so guidance language will draw scrutiny alongside Akamai Technologies results the same day.
Friday brings Humana and Charter Communications, both reporting before the open. Humana faces continued pressure on medical cost ratios in managed care.
No IPOs are scheduled this week. The MSCI World November quarterly review announces on 11 November. Moderna carries an 88% probability of addition, with an estimated $5.9 billion of forced index buying.
Stocks in this article
How this article was generated
- Generated
- 4 Nov 2026, 00:31
- Prompt version
- v1.0
- Data sources
- EarningsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.